Skip Nav Destination
How I treat cryoglobulinemia
Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry
Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminus
A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma
Issue Archive
Table of Contents
INSIDE BLOOD COMMENTARIES
BLOOD SPOTLIGHT
REVIEW ARTICLE
HOW I TREAT
How I treat cryoglobulinemia
CME
Clinical Trials & Observations
CLINICAL TRIALS AND OBSERVATIONS
Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry
Clinical Trials & Observations
Taxiarchis V. Kourelis,Surendra Dasari,Jason D. Theis,Marina Ramirez-Alvarado,Paul J. Kurtin,Morie A. Gertz,Steven R. Zeldenrust,Roman M. Zenka,Ahmet Dogan,Angela Dispenzieri
HEMATOPOIESIS AND STEM CELLS
Distinct signaling programs control human hematopoietic stem cell survival and proliferation
David J. H. F. Knapp,Colin A. Hammond,Nima Aghaeepour,Paul H. Miller,Davide Pellacani,Philip A. Beer,Karen Sachs,Wenlian Qiao,WeiJia Wang,R. Keith Humphries,Guy Sauvageau,Peter W. Zandstra,Sean C. Bendall,Garry P. Nolan,Carl Hansen,Connie J. Eaves
Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminus
Brief Report
Monica Cusan,Naidu M. Vegi,Medhanie A. Mulaw,Shiva Bamezai,Lisa M. Kaiser,Aniruddha J. Deshpande,Philipp A. Greif,Leticia Quintanilla-Fend,Stefanie Göllner,Carsten Müller-Tidow,Keith R. Humphries,Scott A. Armstrong,Wolfgang Hiddemann,Michaela Feuring-Buske,Christian Buske
LYMPHOID NEOPLASIA
B-cell receptor–driven MALT1 activity regulates MYC signaling in mantle cell lymphoma
Beiying Dai,Michael Grau,Mélanie Juilland,Pavel Klener,Elisabeth Höring,Jan Molinsky,Gisela Schimmack,Sietse M. Aukema,Eva Hoster,Niklas Vogt,Annette M. Staiger,Tabea Erdmann,Wendan Xu,Kristian Erdmann,Nicole Dzyuba,Hannelore Madle,Wolfgang E. Berdel,Marek Trneny,Martin Dreyling,Korinna Jöhrens,Peter Lenz,Andreas Rosenwald,Reiner Siebert,Alexandar Tzankov,Wolfram Klapper,Ioannis Anagnostopoulos,Daniel Krappmann,German Ott,Margot Thome,Georg Lenz
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia
Prisca Theunissen,Ester Mejstrikova,Lukasz Sedek,Alita J. van der Sluijs-Gelling,Giuseppe Gaipa,Marius Bartels,Elaine Sobral da Costa,Michaela Kotrová,Michaela Novakova,Edwin Sonneveld,Chiara Buracchi,Paola Bonaccorso,Elen Oliveira,Jeroen G. te Marvelde,Tomasz Szczepanski,Ludovic Lhermitte,Ondrej Hrusak,Quentin Lecrevisse,Georgiana Emilia Grigore,Eva Froňková,Jan Trka,Monika Brüggemann,Alberto Orfao,Jacques J. M. van Dongen,Vincent H. J. van der Velden,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium,on behalf of the EuroFlow Consortium
MYELOID NEOPLASIA
p53−/− synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia
Jingfang Zhang,Guangyao Kong,Adhithi Rajagopalan,Li Lu,Jingming Song,Mohamed Hussaini,Xinmin Zhang,Erik A. Ranheim,Yangang Liu,Jinyong Wang,Xin Gao,Yuan-I Chang,Kirby D. Johnson,Yun Zhou,David Yang,Bhavana Bhatnagar,David M. Lucas,Emery H. Bresnick,Xuehua Zhong,Eric Padron,Jing Zhang
CCL2 is a KIT D816V–dependent modulator of the bone marrow microenvironment in systemic mastocytosis
Georg Greiner,Nadine Witzeneder,Angelika Berger,Klaus Schmetterer,Gregor Eisenwort,Ana-Iris Schiefer,Simone Roos,Theresia Popow-Kraupp,Leonhard Müllauer,Johannes Zuber,Veronika Sexl,Lukas Kenner,Wolfgang R. Sperr,Peter Valent,Matthias Mayerhofer,Gregor Hoermann
LETTERS TO BLOOD
A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma
Clinical Trials & Observations
Barbara Kiesewetter,Ella Willenbacher,Wolfgang Willenbacher,Alexander Egle,Peter Neumeister,Daniela Voskova,Marius Erik Mayerhoefer,Ingrid Simonitsch-Klupp,Thomas Melchardt,Richard Greil,Markus Raderer,for the AGMT Investigators,for the AGMT Investigators,for the AGMT Investigators,for the AGMT Investigators,for the AGMT Investigators,for the AGMT Investigators,for the AGMT Investigators,for the AGMT Investigators,for the AGMT Investigators,for the AGMT Investigators,for the AGMT Investigators
BLOOD WORK
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS
-
Cover Image
Cover Image
![issue cover]()
Immunohistochemical staining for the cytokine CCL2 on a bone marrow section of a patient with systemic mastocytosis. See the article by Greiner et al on page 371.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
